Publications by authors named "Gerald Valette"

Claim this Profile
I
Integration of 18-FDG PET/CT in the Initial Work-Up to Stage Head and Neck Cancer: Prognostic Significance and Impact on Therapeutic Decision Making.
Jean-Christophe Leclere, Olivier Delcroix, Jean Rousset, Gerald Valette, Philippe Robin

Front Med (Lausanne)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic evaluation of percentage variation of metabolic tumor burden calculated by dual-phase (18) FDG PET-CT imaging in patients with head and neck cancer.
Ronan Abgral, Gérald Valette, Philippe Robin, Jean Rousset, Nathalie Keromnes

Head Neck· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatment.
Philippe Robin, Ronan Abgral, Gérald Valette, Pierre-Yves Le Roux, Nathalie Keromnes

Eur J Nucl Med Mol Imaging· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma.
Ronan Abgral, Nathalie Keromnes, Philippe Robin, Pierre-Yves Le Roux, David Bourhis, Gérald Valette

Eur J Nucl Med Mol Imaging· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early recurrence or submucosal residual of laryngeal squamous cell carcinoma: diagnosis by CT-guided endolaryngeal core biopsy on a transcutaneous approach.
Jean Rousset, Ronan Abgral, Sandra Chinellato, Marc Garetier, Céline Barberot, Gérald Valette

Head Neck· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of dual-time-point 18F-FDG PET-CT imaging in patients with head and neck squamous cell carcinoma.
Ronan Abgral, Pierre-Yves Le Roux, Jean Rousset, Solène Querellou, Gérald Valette

Nucl Med Commun· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinoma.
Ronan Abgral, Pierre-Yves Le Roux, Nathalie Keromnes, Jean Rousset, Gérald Valette

Eur J Nucl Med Mol Imaging· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of fluorine-18 fluorodeoxyglucose positron-emission tomography imaging in patients with head and neck squamous cell carcinoma.
Solène Querellou, Ronan Abgral, Pierre-Yves Le Roux, Emmanuel Nowak, Gérald Valette

Head Neck· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18F-FDG PET/CT in primary non-Hodgkin's lymphoma of the sinonasal tract.
Adrian Tempescul, Solene Querellou, Jean-Christophe Ianotto, Sylvie Boisramé, Gerald Valette

Ann Hematol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up?
Pierre Y Salaun, Ronan Abgral, Solène Querellou, Olivier Couturier, Gérald Valette

Head Neck· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis